Publications by authors named "Peter Heining"

Claim this Profile
V
Vehicle Systems and Excipients Used in Minipig Drug Development Studies.
Margaret L Weaver, Anette Blak Grossi, Jorgen Schützsack, Joanna Parish, Jeanet Løgsted, Peter Heining

Toxicol Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Minipig in Drug Discovery and Development: Pros and Cons of Minipig Selection and Strategies to Use as a Preferred Nonrodent Species.
Peter Heining, Tristan Ruysschaert

Toxicol Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential of Minipigs in the Development of Anticancer Therapeutics: Species Comparison and Examples of Special Applications.
Andreas Mahl, Zuhal Dincer, Peter Heining

Toxicol Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
Curtis Colleton, David Brewster, Anne Chester, David O Clarke, Peter Heining

Toxicol Pathol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Goeril Karlsson, Gordon Francis, Gideon Koren, Peter Heining, Xiaoli Zhang

Neurology· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.
Shifeng Pan, Nathanael S Gray, Wenqi Gao, Yuan Mi, Yi Fan, Peter Heining

ACS Med Chem Lett· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.
Volker Brinkmann, Andreas Billich, Thomas Baumruker, Peter Heining, Robert Schmouder

Nat Rev Drug Discov· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses.
Guy M L Meno-Tetang, Hongshan Li, Suzette Mis, Nancy Pyszczynski, Peter Heining

Drug Metab Dispos· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and cell trafficking dynamics of 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride (FTY720) in cynomolgus monkeys after single oral and intravenous doses.
Hongshan Li, Guy M L Meno-Tetang, Kenji Chiba, Noriyuki Arima, Peter Heining

J Pharmacol Exp Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis